Skip to main
SOLV

Solventum Corporation (SOLV) Stock Forecast & Price Target

Solventum Corporation (SOLV) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 10%

Bulls say

Solventum is poised for strong growth and continued margin expansion with the potential for upside from M&A and divestment opportunities and a focus on shareholder returns. The company's separation from 3M in 2024 has provided them with a solid foundation to operate independently and unlock value for shareholders. With a disciplined approach and potential catalysts on the horizon, SOLV has a positive outlook for the future.

Bears say

Solventum is experiencing strong performance in its Dental business, driven by new product launches and a shift towards higher-margin products. However, the overall market growth rate is normalizing, and Solventum's success may have been aided by an early investment cycle. Additionally, management has announced plans to separate the HIS segment, which could lead to shareholder value being unlocked. However, they have not yet begun a formal sale process and are likely to use proceeds for debt reduction and capital return rather than large-scale M&A.

Solventum Corporation (SOLV) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Solventum Corporation (SOLV) Forecast

Analysts have given Solventum Corporation (SOLV) a Buy based on their latest research and market trends.

According to 10 analysts, Solventum Corporation (SOLV) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $91.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $91.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Solventum Corporation (SOLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.